Skip to main content
Open Access Publications from the University of California

Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease

  • Author(s): Toda-Brito, H
  • Lopes, L
  • Soares-Almeida, L
  • Filipe, P
  • et al.
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License

Anti-tumor necrosis factor (anti-TNF) agents have been successfully used to treat both chronic idiopathic inflammatory bowel disease and other immune-mediated chronic diseases, but they can also induce a wide array of cutaneous reactions, including new-onset psoriasis and alopecia. We report a case of alopecia associated with psoriasiform skin lesions in a patient on adalimumab treatment for Crohn's disease.

Main Content
Current View